Physician

Harris Chauhdry Sultan, MD

According to 2025 Medicare claims, Harris Sultan, MD (NPI: 1669890570) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 07666-1704. Sultan is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Sultan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 806 traditional Medicare patients, billed 26,099 HCPCS/CPT codes, and received $3,919,201 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 654 prescription claims across 184 beneficiaries totaling $52,508 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 27 records totaling $6,630. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $47,701 to $3,919,201. Similarly, Part D prescription costs have risen steadily, from $16,082 to $52,508. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$3.9M2018 Medicare payment: $47,701 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $126,145 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $240,576 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,354,809 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,546,917 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,292,283 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,919,201 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018137430$47,701
2019294769$126,145
20203001,397$240,576
20211,0018,447$1,354,809
20221,08814,592$2,546,917
202396823,040$3,292,283
202480626,099$3,919,201

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$64K2015 Drug cost: $16,082 (USD; Tot_Drug_Cst)2016 Drug cost: $19,340 (USD; Tot_Drug_Cst)2017 Drug cost: $23,816 (USD; Tot_Drug_Cst)2018 Drug cost: $3,921 (USD; Tot_Drug_Cst)2019 Drug cost: $4,673 (USD; Tot_Drug_Cst)2020 Drug cost: $5,411 (USD; Tot_Drug_Cst)2021 Drug cost: $31,581 (USD; Tot_Drug_Cst)2022 Drug cost: $63,987 (USD; Tot_Drug_Cst)2023 Drug cost: $59,066 (USD; Tot_Drug_Cst)2024 Drug cost: $52,508 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201528213$16,082
201655220$19,340
2017100266$23,816
20183461$3,921
201943100$4,673
202051111$5,411
2021134401$31,581
2022195677$63,987
2023174638$59,066
2024184654$52,508

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0177Injection, aflibercept hd, 1 mg1745,648$264
67028Injection of drug into eye3461,769$105
92014Established patient complete exam of visual system7112,149$104
92134Imaging of retina6852,215$36
92202Extended exam of the back part of the eye with optic nerve drawing5881,630$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1888,704$9,733
ProlensaBromfenac Sodium28730$9,651
Bromfenac SodiumBromfenac Sodium32731$5,500
CombiganBrimonidine Tartrate/Timolol13665$3,813
Ketorolac TromethamineKetorolac Tromethamine582,179$1,688

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$651Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.5$5,979Apellis Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Harris Chauhdry Sultan, MD?

Tedicare shows public-source Medicare data for Harris Chauhdry Sultan, MD (NPI 1669890570), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harris Chauhdry Sultan, MD have ACO affiliation data?

Harris Chauhdry Sultan, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Harris Chauhdry Sultan, MD?

Harris Chauhdry Sultan, MD is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Harris Chauhdry Sultan, MD have Open Payments data?

Harris Chauhdry Sultan, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.